Legal & General Group PLC Cara Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $257,595 - $449,653	-91,023 Reduced 95.45%	4,335 $12,000
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $59,922 - $150,356	-12,254 Reduced 11.39%	95,358 $468,000
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $20,148 - $28,975	2,269 Added 2.15%	107,612 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $54,120 - $82,494	6,568 Added 6.65%	105,343 $986,000
Q2 2022 Aug 22, 2022	SELL	$7.45 - $13.84 $10,780 - $20,026	-1,447 Reduced 1.44%	98,775 $902,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $9,105 - $11,587	-916 Reduced 0.91%	100,222 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $44,087 - $66,700	3,677 Added 3.77%	101,138 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $73,642 - $102,398	6,376 Added 7.0%	97,461 $1.51 Million
Q2 2021 Aug 12, 2021	BUY	$12.38 - $29.19 $1.03 Million - $2.44 Million	83,544 Added 1107.86%	91,085 $1.3 Million
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $512 - $738	34 Added 0.45%	7,541 $163,000
Q3 2020 Nov 13, 2020	SELL	$12.34 - $17.92 $23,026 - $33,438	-1,866 Reduced 19.91%	7,507 $96,000
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $6,777 - $9,479	547 Added 6.2%	9,373 $160,000
Q1 2020 May 14, 2020	SELL	$9.12 - $17.78 $15,385 - $29,994	-1,687 Reduced 16.05%	8,826 $116,000
Q4 2019 Feb 13, 2020	BUY	$16.11 - $25.98 $20,717 - $33,410	1,286 Added 13.94%	10,513 $170,000
Q3 2019 Nov 13, 2019	BUY	$18.28 - $26.91 $17,457 - $25,699	955 Added 11.54%	9,227 $168,000
Q2 2019 Aug 14, 2019	BUY	$17.68 - $21.57 $42,591 - $51,962	2,409 Added 41.09%	8,272 $178,000
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $4,683 - $6,383	325 Added 5.87%	5,863 $115,000
Q3 2018 Nov 20, 2018	BUY	$17.57 - $23.95 $25,863 - $35,254	1,472 Added 36.2%	5,538 $132,000
Q2 2018 Aug 10, 2018	SELL	$11.6 - $19.27 $11,194 - $18,595	-965 Reduced 19.18%	4,066 $78,000
Q1 2018 May 17, 2018	SELL	$11.77 - $16.08 $23,928 - $32,690	-2,033 Reduced 28.78%	5,031 $62,000
Q4 2017 Feb 13, 2018	BUY	$11.86 - $14.08 $83,779 - $99,461	7,064	7,064 $88,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$607,205
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$459,569
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$420,187
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$300,521
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$299,411
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account